Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain. [PDF]
Zahrieh D +12 more
europepmc +1 more source
Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adults. [PDF]
White LE +7 more
europepmc +1 more source
Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor use and sexual dysfunction: a pharmacovigilance analysis. [PDF]
Shen M +6 more
europepmc +1 more source
Comparative analysis of male stress urinary incontinence treatments: A review of efficacy, safety, and clinical outcomes. [PDF]
Kosuru S +5 more
europepmc +1 more source
Diosmetin as an Effective Treatment for Cisplatin-Induced Neuropathic Pain in Mice which does not Cause Hepatic or Renal Biomarker Alterations. [PDF]
Serafini PT +3 more
europepmc +1 more source
Methotrexate toxicity due to a medication dispensing error compounded by an interaction with proton pump inhibitors. [PDF]
Chakrabarti A +4 more
europepmc +1 more source
Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression. [PDF]
Balic N +17 more
europepmc +1 more source
The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial. [PDF]
Wang S +7 more
europepmc +1 more source
Evaluating efficacy of pregabalin in diabetic peripheral neuropathy pain management. [PDF]
Joseph T +5 more
europepmc +1 more source
Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. [PDF]
Lavoie Smith EM +21 more
europepmc +1 more source

